You are here
Teva said to be close to buying generic drug unit of Allergan
Petah Tikva, Israel
TEVA Pharmaceuticals is in advanced talks to buy the generic drug division of Allergan for about US$45 billion, a person briefed on the matter said on Saturday.
A deal could be announced as soon as Monday, this person said, though talks are ongoing and may still
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org